from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2004c/-

LFCtreatmentdescriptionclass of inhibitor

-0.231

Amikacinug/mL Amikacintranslation

-0.664

Cap5-10ug/mL Capreomycintranslation

-0.477

Rox10-50 ug/mL Roxithromycintranslation

-0.331

SM2-5 ug/mL Streptomycintranslation

-0.045

Tet5-10 ug/mL Tetracyclinetranslation

-0.068

Rif0.2-5ug/mL Rifampicintranscription

-0.750

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.193

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.631

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.028

CPZ10-50 ug/mL Chlorpromazinerespiration

0.155

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.152

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

2.491

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.341

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.555

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.290

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.426

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.036

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.593

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.445

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

2.010

KCN5-20 ug/mL Potassium cyaniderespiration

-1.000

NaN30.2-2 mM Sodium aziderespiration

0.154

Nigericin50 uM Nigericinrespiration

0.461

TRC10-150 ug/mL Triclosanrespiration

0.769

TRZ10-25 ug/mL Thioridazinerespiration

0.632

Valinomycin0.5-10 uM Valinomycinrespiration

0.039

ZnSO42 mM ZnSO4respiration

-0.187

menadione6-10 ug/mL Menadionerespiration

-0.689

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.517

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.509

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.398

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

3.213

NRP_1Non-replicating persistence stage 1dosRassociated

-0.314

Amp0.2mg/mL AmpicillincellWall

-0.448

Cephalexin20-100 ug/mL CephalexincellWall

-0.287

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.340

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.269

EMB10-20 ug/mL EthambutolcellWall

-0.332

Eta12-40 ug/mL EthionamidecellWall

-0.304

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.479

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.293

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.459

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.000

BZA0.12 mg/mL BenzamidearomaticAmides

0.000

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.000

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.000

H2O24 mM hydrogen peroxideDNAdamaging

-0.789

Levo10 ug/mL LevofloxacinDNAdamaging

0.000

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.732

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.409

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.000

UVUV-irradiationDNAdamaging

0.513

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.606

Antimycin12.5-50 ug/mL Antimycin A?

-0.425

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-1.023

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.546

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.487

PA8240.2-2 ug/mL PA-824?

1.651

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.149

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.506

Verapamil50 uM Verapamil?

-0.426

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.158

methoxatin10-20 ug/mL Methoxatin?